Abstract
A significant mortality rate is associated with oral cancer, particularly in cases of late-stage diagnosis. Since the last decades, oral cancer survival rates have only gradually improved despite advances in treatment. This poor success rate is mainly due to the development of secondary tumors, local recurrence, and regional failure. Invasive treatments frequently have a negative impact on the aesthetic and functional outcomes of survivors. Novel approaches are thus needed to manage this deadly disease in light of these statistics. In photodynamic therapy (PDT), a light-sensitive medication called a photosensitizer is given first, followed by exposure to light of the proper wavelength that matches the absorbance band of the photosensitizer. The tissue oxygen-induced cytotoxic free radicals kill tumor cells directly, harm the microvascular structure, and cause inflammatory reactions at the targeted sites. In the case of early lesions, PDT can be used as a stand-alone therapy, and in the case of advanced lesions, it can be used as adjuvant therapy. The current review article discussed the uses of PDT in oral cancer therapy based on recent advances in this field.
Similar content being viewed by others
Data availability
Not applicable.
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91(1):13–23.
Leemans CR, Snijders PJ, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269.
Scully C, Porter S. Oral cancer. West J Med. 2001;174(5):348–51.
Hwang E, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M. Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007. Oral Oncol. 2013;49(11):1072–6.
Allen L, Williams J, Townsend N, Mikkelsen B, Roberts N, Foster C, Wickramasinghe K. Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review. Lancet Glob Health. 2017;5(3):e277–89.
Mummudi N, Agarwal J, Chatterjee S, Mallick I, Ghosh-Laskar S. Oral cavity cancer in the Indian subcontinent–challenges and opportunities. Clin Oncol. 2019;31(8):520–8.
Hsu W-L, Yu KJ, Chiang C-J, Chen T-C, Wang C-P. Head and neck cancer incidence trends in Taiwan, 1980–2014. Int J Head Neck Sci. 2017;1(3):180–9.
Westra WH, Lewis JS. Update from the 4th edition of the world health organization classification of head and neck tumours: oropharynx. Head Neck Pathol. 2017;11(1):41–7.
VanderWalde NA, Fleming M, Weiss J, Chera BS. Treatment of older patients with head and neck cancer: a review. Oncologist. 2013;18(5):568–78.
Santoni A, Santoni M, Arcuri E. Chronic cancer pain: opioids within tumor microenvironment affect neuroinflammation, tumor and pain evolution. Cancers (Basel). 2022;14(9):2253.
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.
Huber MA, Tantiwongkosi B. Oral and oropharyngeal cancer. Med Clin North Am. 2014;98(6):1299–321.
Rokaya D. Role of maxillofacial prosthetics in the head-and-neck cancer rehabilitation. Saint’s Int Dental J. 2021;5(2):35–35.
Amornvit P, Rokaya D, Shrestha B, Srithavaj T. Prosthetic rehabilitation of an ocular defect with post-enucleation socket syndrome: a case report. Saudi Dent J. 2014;26(1):29–32.
Humagain M, Rokaya D. Integrating digital technologies in dentistry to enhance the clinical success. Kathmandu Univ Med J (KUMJ). 2019;17(68):256–7.
Alqurashi H, Khurshid Z, Syed AUY, Rashid Habib S, Rokaya D, Zafar MS. Polyetherketoneketone (PEKK): an emerging biomaterial for oral implants and dental prostheses. J Adv Res. 2021;28:87–95.
Kolokythas A. Long-term surgical complications in the oral cancer patient: a comprehensive review. Part I. J Oral Maxillofac Res. 2010;1(3):e1.
Rigual N, Shafirstein G, Cooper MT, Baumann H, Bellnier DA, Sunar U, Tracy EC, Rohrbach DJ, Wilding G, Tan W, Sullivan M, Merzianu M, Henderson BW. Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res. 2013;19(23):6605–13.
Rigual NR, Thankappan K, Cooper M, Sullivan MA, Dougherty T, Popat SR, Loree TR, Biel MA, Henderson B. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg. 2009;135(8):784–8.
Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34(1):39–43.
Epstein JB, Thariat J, Bensadoun R-J, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy. CA: Cancer J Clin. 2012;62(6):400–22.
Raber-Durlacher JE, Barasch A, Peterson DE, Lalla RV, Schubert MM, Fibbe WE. Oral complications and management considerations in patients treated with high-dose chemotherapy. Support Cancer Ther. 2004;1(4):219–29.
Dreizen S, Daly TE, Drane JB, Brown LR. Oral complications of cancer radiotherapy. Postgrad Med. 1977;61(2):85–92.
Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. The patient’s perspective. Cancer Nurs. 2002;25(6):461–7.
Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918–31.
Nauta JM, van Leengoed HL, Star WM, Roodenburg JL, Witjes MJ, Vermey A. Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications. Eur J Oral Sci. 1996;104:69–81.
Saini R, Lee NV, Liu KY, Poh CF. Prospects in the application of photodynamic therapy in oral cancer and premalignant lesions. Cancers (Basel). 2016;8(9):83.
Al-Sharif RM, Batwa DY, Alotaibi TN, Alwadai NM, Alsharif AH, Azhar NA, Moulana AA, Alahmadi SM, Althobaiti MY, Bayyumi DF, Alzahrani WI. Epidemiology and types of oral cancer. Int J Commut Med Public Health. 2022;9(2):6.
Banakar M, Ardekani ST, Zare R, Malekzadeh M, Mirhadi H, Khademi B, Rokaya D. Oral squamous cell carcinoma: the role of BIRC6 serum level. Biomed Res Int. 2022;2022:5425478.
Nyst HJ, Tan IB, Stewart FA, Balm AJ. Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? Photodiagn Photodyn Ther. 2009;6(1):3–11.
Allison RR, Bagnato VS, Sibata CH. Future of oncologic photodynamic therapy. Future Oncol. 2010;6(6):929–40.
Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380–7.
Robertson CA, Evans DH, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B Biol. 2009;96(1):1–8.
Raghavendra M, Koregol A, Bhola S. Photodynamic therapy: a targeted therapy in periodontics. Aust Dent J. 2009;54(Suppl 1):S102–9.
Shafirstein G, Friedman A, Siegel E, Moreno M, Bäumler W, Fan CY, Morehead K, Vural E, Stack BC Jr, Suen JY. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia. Arch Otolaryngol Head Neck Surg. 2011;137(11):1117–23.
Harada Y, Murayama Y, Takamatsu T, Otsuji E, Tanaka H. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence imaging for tumor detection: recent advances and challenges. Int J Mol Sci. 2022;23(12):6478.
Romeo U, Russo N, Palaia G, Tenore G, Del Vecchio A. Oral proliferative verrucous leukoplakia treated with the photodynamic therapy: a case report. Ann Stomatol. 2014;5(2):77–80.
Soukos NS, Goodson JM. Photodynamic therapy in the control of oral biofilms. Periodontology. 2011;55(1):143–66.
Mostafa D, Tarakji B. Photodynamic therapy in treatment of oral lichen planus. J Clin Med Res. 2015;7(6):393–9.
Choi SH, Kim KH, Song KH. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial. Br J Dermatol. 2015;173(1):184–91.
Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM. Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Lasers Surg Med. 2006;38(1):33–8.
Takasaki AA, Aoki A, Mizutani K, Schwarz F, Sculean A, Wang CY, Koshy G, Romanos G, Ishikawa I, Izumi Y. Application of antimicrobial photodynamic therapy in periodontal and peri-implant diseases. Periodontology. 2009;2000(51):109–40.
Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Fateh M, Djavid GE. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: a case report. Med Oral, Patol Oral y Cirugia Bucal. 2006;11(2):E126–9.
Sadaksharam J, Nayaki KP, Selvam NP. Treatment of oral lichen planus with methylene blue mediated photodynamic therapy–a clinical study. Photodermatol Photoimmunol Photomed. 2012;28(2):97–101.
Pavlic V, Vujic-Aleksic V. Phototherapy approaches in treatment of oral lichen planus. Photodermatol Photoimmunol Photomed. 2014;30(1):15–24.
Sobaniec S, Bernaczyk P, Pietruski J, Cholewa M, Skurska A, Dolińska E, Duraj E, Tokajuk G, Paniczko A, Olszewska E, Pietruska M. Clinical assessment of the efficacy of photodynamic therapy in the treatment of oral lichen planus. Lasers Med Sci. 2013;28(1):311–6.
Ali-Seyed M, Bhuvaneswari R, Soo KC, Olivo M. Photolon™—photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Int J Oncol. 2011;39(4):821–31.
Andreadis D, Pavlou A-M, Sotiriou E, Vrani F, Ioannides D, Kolokotronis A. Utility of photodynamic therapy for the management of oral potentially malignant disorders and oral cancer. Transl Res Oral Oncol. 2016. https://doi.org/10.1177/2057178X16669161.
Jajarm HH, Falaki F, Sanatkhani M, Ahmadzadeh M, Ahrari F, Shafaee H. A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial. Lasers Med Sci. 2015;30(5):1475–80.
Zanin IC, Lobo MM, Rodrigues LK, Pimenta LA, Höfling JF, Gonçalves RB. Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci. 2006;114(1):64–9.
Usacheva MN, Teichert MC, Biel MA. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med. 2001;29(2):165–73.
Kim MM, Darafsheh A. Light sources and dosimetry techniques for photodynamic therapy. Photochem Photobiol. 2020;96(2):280–94.
Mang TS. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1(1):43–8.
Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002;17(3):173–86.
Wilson BC. Photodynamic therapy: light delivery and dosage for second-generation photosensitizers. Ciba Found Symp. 1989;146:60–73.
Saleh BEA, Teich MC. Fundamentals of photonics. Hoboken: Wiley; 2019.
Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, Chiang CP. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med. 2005;37(2):114–22.
Tsai JC, Chiang CP, Chen HM, Huang SB, Wang CW, Lee MI, Hsu YC, Chen CT, Tsai T. Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Lasers Surg Med. 2004;34(1):18–24.
Yu CH, Lin HP, Chen HM, Yang H, Wang YP, Chiang CP. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light. Lasers Surg Med. 2009;41(9):628–33.
Hempstead J, Jones DP, Ziouche A, Cramer GM, Rizvi I, Arnason S, Hasan T, Celli JP. Low-cost photodynamic therapy devices for global health settings: characterization of battery-powered LED performance and smartphone imaging in 3D tumor models. Sci Rep. 2015;5:10093.
Chen J, Keltner L, Christophersen J, Zheng F, Krouse M, Singhal A, Wang SS. New technology for deep light distribution in tissue for phototherapy. Cancer J (Sudbury, Mass). 2002;8(2):154–63.
Schmidt MH, Bajic DM, Reichert KW 2nd, Martin TS, Meyer GA, Whelan HT. Light-emitting diodes as a light source for intraoperative photodynamic therapy. Neurosurgery. 1996;38(3):552–6.
Burch S, London C, Seguin B, Rodriguez C, Wilson BC, Bisland SK. Treatment of canine osseous tumors with photodynamic therapy: a pilot study. Clin Orthop Relat Res. 2009;467(4):1028–34.
Wilson BC, Patterson MS. The physics of photodynamic therapy. Phys Med Biol. 1986;31(4):327–60.
Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–66.
Vohra F, Al-Kheraif AA, Qadri T, Hassan MI, Ahmed A, Warnakulasuriya S, Javed F. Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review. Photodiagn Photodyn Ther. 2015;12(1):150–9.
Cerrati EW, Nguyen SA, Farrar JD, Lentsch EJ. The efficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis. Ear Nose Throat J. 2015;94(2):72–9.
Bredell MG, Besic E, Maake C, Walt H. The application and challenges of clinical PD-PDT in the head and neck region: a short review. J Photochem Photobiol B Biol. 2010;101(3):185–90.
Allison RR, Sibata C, Gay H. PDT for cancers of the head and neck. Photodiagn Photodyn Ther. 2009;6(1):1–2.
Biel MA. Photodynamic therapy of head and neck cancers. Methods Mol Biol (Clifton, NJ). 2010;635:281–93.
Tan IB, Dolivet G, Ceruse P, Vander Poorten V, Roest G, Rauschning W. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck. 2010;32(12):1597–604.
Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 1996;78(7):1374–83.
Konopka K, Goslinski T. Photodynamic therapy in dentistry. J Dent Res. 2007;86(8):694–707.
D’Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck. 2004;26(3):232–40.
Jerjes W, Upile T, Akram S, Hopper C. The surgical palliation of advanced head and neck cancer using photodynamic therapy. Clin Oncol. 2010;22(9):785–91.
Li LB, Luo RC, Liao WJ, Zhang MJ, Luo YL, Miao JX. Clinical study of photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma. Photodiagn Photodyn Ther. 2006;3(4):266–71.
Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212–9.
Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med. 2007;39(5):386–93.
Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer. 2004;91(3):441–6.
Karakullukcu B, Nyst HJ, van Veen RL, Hoebers FJ, Hamming-Vrieze O, Witjes MJ, de Visscher SA, Burlage FR, Levendag PC, Sterenborg HJ, Tan IB. mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: development of a new method. Head Neck. 2012;34(11):1597–606.
Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs. 1994;5(4):443–7.
Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61(1):192–6.
Reis Sousa C. Activation of dendritic cells: translating innate into adaptive immunity. Curr Opin Immunol. 2004;16(1):21–5.
Sur BW, Nguyen P, Sun CH, Tromberg BJ, Nelson EL. Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection. Photochem Photobiol. 2008;84(5):1257–64.
Saji H, Song W, Furumoto K, Kato H, Engleman EG. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res. 2006;12(8):2568–74.
Kim SG, Hong JW, Boo SH, Kim MG, Lee KD, Ahn JC, Hwang HJ, Shin JI, Lee SJ, Oh JK, Chung PS. Combination treatment of cetuximab and photodynamic therapy in SNU-1041 squamous cancer cell line. Oncol Rep. 2009;22(4):701–8.
Ge R, Ahn JC, Shin JI, Bahk CW, He P, Chung PS. An in vitro and in vivo study of combination therapy with photogem®-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26). Photomed Laser Surg. 2011;29(3):155–60.
Compagnin C, Mognato M, Celotti L, Canti G, Palumbo G, Reddi E. Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy. Cell Prolif. 2010;43(3):262–74.
Datta SN, Allman R, Loh C, Mason M, Matthews PN. Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line. Br J Cancer. 1997;76(3):312–7.
Civantos FJ, Karakullukcu B, Biel M, Silver CE, Rinaldo A, Saba NF, Takes RP, Vander Poorten V, Ferlito A. A review of photodynamic therapy for neoplasms of the head and neck. Adv Ther. 2018;35(3):324–40.
Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med. 2006;38(5):522–31.
Carcenac M, Larroque C, Langlois R, van Lier JE, Artus JC, Pèlegrin A. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. Photochem Photobiol. 1999;70(6):930–6.
Hamblin MR, Newman EL. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J Photochem Photobiol B Biol. 1994;26(2):147–57.
Carcenac M, Dorvillius M, Garambois V, Glaussel F, Larroque C, Langlois R, Hynes NE, van Lier JE, Pèlegrin A. Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates. Br J Cancer. 2001;85(11):1787–93.
Yarmush ML, Thorpe WP, Strong L, Rakestraw SL, Toner M, Tompkins RG. Antibody targeted photolysis. Crit Rev Ther Drug Carrier Syst. 1993;10(3):197–252.
Smith KA, Nelson PN, Warren P, Astley SJ, Murray PG, Greenman J. Demystified recombinant antibodies. J Clin Pathol. 2004;57(9):912–7.
Staneloudi C, Smith KA, Hudson R, Malatesti N, Savoie H, Boyle RW, Greenman J. Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer. Immunology. 2007;120(4):512–7.
Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008;60(15):1627–37.
Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Baba Y. Quantum dots as photosensitizers? Nat Biotechnol. 2004;22(11):1360–1.
Ma J, Chen JY, Idowu M, Nyokong T. Generation of singlet oxygen via the composites of water-soluble thiol-capped CdTe quantum dots-sulfonated aluminum phthalocyanines. J Phys Chem B. 2008;112(15):4465–9.
Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 2008;26(11):612–21.
Hamblin MR. Advances in photodynamic therapy: basic, translational, and clinical. Norwood: Artech House; 2008.
Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol. 2006;6(4):1159–66.
Zhang P, Steelant W, Kumar M, Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J Am Chem Soc. 2007;129(15):4526–7.
Wang C, Tao H, Cheng L, Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials. 2011;32(26):6145–54.
Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm. 2006;3(4):415–23.
Oo MK, Yang X, Du H, Wang H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine (Lond). 2008;3(6):777–86.
Chen B, Pogue BW, Hoopes PJ, Hasan T. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr. 2006;16(4):279–305.
Kurohane K, Tominaga A, Sato K, North JR, Namba Y, Oku N. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett. 2001;167(1):49–56.
Chen B, Crane C, He C, Gondek D, Agharkar P, Savellano MD, Hoopes PJ, Pogue BW. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int J Cancer. 2008;123(3):695–701.
Starkey JR, Rebane AK, Drobizhev MA, Meng F, Gong A, Elliott A, McInnerney K, Spangler CW. New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse. Clin Cancer Res. 2008;14(20):6564–73.
Collins HA, Khurana M, Moriyama EH, Mariampillai A, Dahlstedt E, Balaz M, Kuimova MK, Drobizhev M, Yang VXD, Phillips D, Rebane A, Wilson BC, Anderson HL. Blood-vessel closure using photosensitizers engineered for two-photon excitation. Nat Photonics. 2008;2(7):420–4.
Brown S. Two photons are better than one. Nat Photonics. 2008;2(7):394–5.
Karotki A, Khurana M, Lepock JR, Wilson BC. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy. Photochem Photobiol. 2006;82(2):443–52.
Korbelik M. Cancer vaccines generated by photodynamic therapy. Photochem Photobiol Sci: Off J Eur Photochem Assoc Eur Soc Photobiol. 2011;10(5):664–9.
Holsinger FC, Ferris RL. Transoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trials. J Clin Oncol. 2015;33(29):3285.
Quon H, Finlay J, Cengel K, Zhu T, O’Malley B Jr, Weinstein G. Transoral robotic photodynamic therapy for the oropharynx. Photodiagn Photodyn Ther. 2011;8(1):64–7.
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA: Cancer J Clin. 2011;61(4):250–81.
Selbo PK, Weyergang A, Høgset A, Norum OJ, Berstad MB, Vikdal M, Berg K. Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J Control Release: Off J Control Release Soc. 2010;148(1):2–12.
Jerjes W, Theodossiou TA, Hirschberg H, Høgset A, Weyergang A, Selbo PK, Hamdoon Z, Hopper C, Berg K. Photochemical internalization for intracellular drug delivery: from basic mechanisms to clinical research. J Clin Med. 2020;9(2):528.
Berg K, Folini M, Prasmickaite L, Selbo PK, Bonsted A, Engesaeter B, Zaffaroni N, Weyergang A, Dietze A, Maelandsmo GM, Wagner E, Norum OJ, Høgset A. Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol. 2007;8(6):362–72.
Alzeibak R, Mishchenko TA, Shilyagina NY, Balalaeva IV, Vedunova MV, Krysko DV. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J Immunother Cancer. 2021;9(1):e001926.
Park S, Hwang J, Kwon Y, Cheon C. Antenna system applicable to microwave non-invasive hyperthermia lipolysis. Electron Lett. 2012;48(19):1179–81.
Muehlmann LA, Joanitti GA, Silva JR, Longo JP, Azevedo RB. Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy. Braz J Med Biol. 2011;44(8):729–37.
Davies AM, Weinberg U, Palti Y. Tumor treating fields: a new frontier in cancer therapy. Ann NY Acad Sci. 2013;1291:86–95.
Saczko J, Nowak M, Skolucka N, Kulbacka J, Kotulska M. The effects of the electro-photodynamic in vitro treatment on human lung adenocarcinoma cells. Bioelectrochemistry (Amsterdam, Netherlands). 2010;79(1):90–4.
Covello G, Siva K, Adami V, Denti MA. An electroporation protocol for efficient DNA transfection in PC12 cells. Cytotechnology. 2014;66(4):543–53.
Charoo NA, Rahman Z, Repka MA, Murthy SN. Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv. 2010;7(2):125–36.
Lambreva M, Glück B, Radeva M, Berg H. Electroporation of cell membranes supporting penetration of photodynamic active macromolecular chromophore dextrans. Bioelectrochemistry (Amsterdam, Netherlands). 2004;62(1):95–8.
Yang M, Yang T, Mao C. Enhancement of photodynamic cancer therapy by physical and chemical factors. Angew Chem Int Ed Engl. 2019;58(40):14066–80.
Pandita TK, Pandita S, Bhaumik SR. Molecular parameters of hyperthermia for radiosensitization. Crit Rev Eukaryot Gene Expr. 2009;19(3):235–51.
Manthe RL, Foy SP, Krishnamurthy N, Sharma B, Labhasetwar V. Tumor ablation and nanotechnology. Mol Pharm. 2010;7(6):1880–98.
Yao M, Ma L, Li L, Zhang J, Lim R, Chen W, Zhang Y. A new modality for cancer treatment-nanoparticle mediated microwave induced photodynamic therapy. J Biomed Nanotechnol. 2016;12(10):1835–51.
Vander Vorst A, Rosen A, Kotsuka Y. RF/microwave interaction with biological tissues. Hoboken: John Wiley & Sons; 2006.
Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Photodynamic therapy outcome for oral dysplasia. Lasers Surg Med. 2011;43(3):192–9.
Sieroń A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2003;32(6):330–6.
Grant WE, Hopper C, Speight PM, Macrobert AJ, Bown SG. Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity. J Laryngol Otol. 1993;107(12):1140–5.
Yu CH, Chen HM, Hung HY, Cheng SJ, Tsai T, Chiang CP. Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion. Oral Oncol. 2008;44(6):595–600.
Lin HP, Chen HM, Yu CH, Yang H, Wang YP, Chiang CP. Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia. J Oral Pathol Med: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2010;39(8):624–30.
Kübler A, Haase T, Rheinwald M, Barth T, Mühling J. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg. 1998;27(6):466–9.
Ikeda H, Tobita T, Ohba S, Uehara M, Asahina I. Treatment outcome of photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia. Photodiagn Photodyn Ther. 2013;10(3):229–35.
Toratani S, Tani R, Kanda T, Koizumi K, Yoshioka Y, Okamoto T. Photodynamic therapy using photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up. Photodiagn Photodyn Ther. 2016;14:104–10.
Jerjes W, Upile T, Hamdoon Z, Alexander Mosse C, Morcos M, Hopper CJLIS. Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma. Lasers Surg Med. 2011;43(6):463–9.
Wang X, Li N, Meng J, Wen NJAJOO. The use of topical ALA-photodynamic therapy combined with induction chemotherapy for locally advanced oral squamous cell carcinoma. Am J Otolaryngol. 2021;42(6):103112.
Ikeda H, Ohba S, Egashira K, Asahina IJP, Therapy P. The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma: a series of eight cases. Photodiag Photodyn Ther. 2018;21:176–80.
Schweitzer VG, Somers ML. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx. Lasers Surg Med. 2010;42(1):1–8.
Karakullukcu B, Stoker SD, Wildeman AP, Copper MP, Wildeman MA, Tan IB. A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer. Eur Arch Oto-Rhino-Laryngol. 2013;270(3):1093–7.
de Visscher SA, Melchers LJ, Dijkstra PU, Karakullukcu B, Tan IB, Hopper C, Roodenburg JL, Witjes MJ. mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment. Ann Surg Oncol. 2013;20(9):3076–82.
Vander Poorten V, Meulemans J, Nuyts S, Clement P, Hermans R, Hauben E, Delaere P. Postoperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongue. World J Surg Oncol. 2015;13(1):1–4.
Jerjes UTW, Hamdoon Z, Abbas S, Akram S, Mosse CA, Morley S, Hopper C. Photodynamic therapy: the minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma. Lasers Surg Med. 2011;43(4):283–92.
van Doeveren TE, Karakullukçu MB, van Veen RL, Lopez-Yurda M, Schreuder WH, Tan IB. Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins. Laryngoscope. 2018;128(3):657–63.
Ahn PH, Quon H, O’Malley BW, Weinstein G, Chalian A, Malloy K, Atkins JH, Sollecito T, Greenberg M, McNulty S. Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors. Oral Oncol. 2016;55:37–42.
Rigual N, Shafirstein G, Cooper MT, Baumann H, Bellnier DA, Sunar U, Tracy EC, Rohrbach DJ, Wilding G, Tan W. Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res. 2013;19(23):6605–13.
Santos LL, Oliveira J, Monteiro E, Santos J, Sarmento CJ. Treatment of head and neck cancer with photodynamic therapy with redaporfin: a clinical case report. Case Rep Oncol. 2018;11(3):769–76.
Hosokawa S, Takebayashi S, Takahashi G, Okamura J, Mineta H. Photodynamic therapy in patients with head and neck squamous cell carcinoma. Lasers Surg Med. 2018;50(5):420–6.
Rigual NR, Shafirstein G, Frustino J, Seshadri M, Cooper M, Wilding G, Sullivan MA, Henderson B. Adjuvant intraoperative photodynamic therapy in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(7):706–11.
Caesar L, van Doeveren T, Tan I, Dilci A, van Veen R, Karakullukcu BJP, Therapy P. The use of photodynamic therapy as adjuvant therapy to surgery in recurrent malignant tumors of the paranasal sinuses. Photodiagn Photodyn Ther. 2015;12(3):414–21.
Shafirstein G, Rigual NR, Arshad H, Cooper MT, Bellnier DA, Wilding G, Tan W, Merzianu M, Henderson BWJH. Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: phase Ib study. Head Neck. 2016;38(S1):E377–83.
von Beckerath MP, Reizenstein JA, Berner AL, Nordqvist KW, Landström FJ, Löfgren AL, Möller CG. Outcome of primary treatment of early laryngeal malignancies using photodynamic therapy. Acta Oto-Laryngol. 2014;134(8):852–8.
Karakullukcu B, van Oudenaarde K, Copper MP, Klop W, van Veen R, Wildeman M, Bing Tan I. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Oto-Rhino-Laryngol. 2011;268(2):281–8.
Lambert A, Nees L, Nuyts S, Clement P, Meulemans J, Delaere P, Vander Poorten V. Photodynamic therapy as an alternative therapeutic tool in functionally inoperable oral and oropharyngeal carcinoma: a single tertiary center retrospective cohort analysis. Front Oncol. 2021;11:626394.
Durbec M, Cosmidis A, Fuchsmann C, Ramade A, Céruse P. Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx. Eur Arch Oto-Rhino-Laryngol. 2013;270(4):1433–9.
Succo G, Rosso S, Fadda G, Fantini M, Crosetti EJP. Salvage photodynamic therapy for recurrent nasopharyngeal carcinoma. Photodiagn Photodyn Ther. 2014;11(2):63–70.
Abbas S, Jerjes W, Upile T, Vaz F, Hopper CJP. The palliative role of PDT in recurrent advanced nasopharyngeal carcinoma: case series. Photodiagn Photodyn Ther. 2012;9(2):142–7.
Stoker S, Indrasari S, Herdini C, Hariwiyanto B, Karakullukcu B, Dhamiyati W, Widayati K, Romdhoni A, Fles R, Haryana SJP, Therapy P. Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy. Photodiagn Photodyn Ther. 2015;12(3):519–25.
Nyst HJ, Wildeman M, Indrasari S, Karakullukcu B, van Veen R, Adham M, Stewart F, Levendag P, Sterenborg H, Tan I. Temoporfin mediated photodynamic therapy in patients with local persistent and recurrent nasopharyngeal carcinoma after curative radiotherapy: a feasibility study. Photodiagn Photodyn Ther. 2012;9(3):274–81.
Acknowledgements
The authors thank their colleagues for their insightful comments.
Funding
There was no funding provided.
Author information
Authors and Affiliations
Contributions
Not applicable.
Corresponding authors
Ethics declarations
Competing interests
The authors claim to have no conflict of interest.
Ethical approval
There is no author-conducted research with humans or animals in this review article.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mosaddad, S.A., Namanloo, R.A., Aghili, S.S. et al. Photodynamic therapy in oral cancer: a review of clinical studies. Med Oncol 40, 91 (2023). https://doi.org/10.1007/s12032-023-01949-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-023-01949-3